Both in Biotechnology
Cel-Sci vs Estrella Immunopharma
Over the past year CVM returned −80.5% and ESLA returned −73.6%; their daily moves had a correlation of 0.19.
CVM −80.5% ESLA −73.6%Growth of $1, one year, split-adjusted
| Metric | CVM | ESLA |
|---|---|---|
| Price | $1.38 | $0.6393 |
| Market cap | $24.3M | $27.8M |
| Today | −8.00% | −12.27% |
| 1 month | −34.0% | +34.6% |
| 6 months | −39.5% | −60.8% |
| Year to date | −73.8% | −59.0% |
| 1 year | −81.8% | −74.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $255.6K | $146.7K |
| Dividend yield | — | — |
| Volatility (60d) | 99.0% | 183.8% |
| Short % of float | 4.0% | 4.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).